Mr. Chair, thank you for the question.
At Health Canada, we have looked at a few aspects of conflicts of interest.
Our main concern was really the fact that we thought the department hadn't really assessed where the risks lie in terms of managing conflict of interest for its reviewers of drug submissions. And really, its processes were meeting Treasury Board requirements, but nothing more.